reference/34831267

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34831267

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	304
issn	0894-1491 1098-1136
issueIdentifier	2
pageRange	284-304
publicationName	Glia
startingPage	284
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_274a87fdd2d7d6aaba9a3774c9e5d285 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d813a34c1e4381504d2b075a53f74917
bibliographicCitation	Luo W, Xu H, Xu L, Jiang W, Chen C, Chang Y, Liu C, Tian Z, Qiu X, Xie C, Li X, Chen H, Lai S, Wu L, Cui Y, Tang C, Qiu W. Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation. Glia. 2023 Feb;71(2):284–304. doi: 10.1002/glia.24271. PMID: 36089914.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73b019ae4ea8f813f5c7923a77cdfad4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1c5d75e714bc08220c02575b2e7988e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0818886e866cb75977c48ace0db45348 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c477e011da723585a275d8ecd7344c6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_948cf3bb4ac7e3d8d4240a3a4f455c94 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0880-958X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db62f301d2d8693db2f6264f6486bce4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0982021c65c063b8717cee39695f2d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_404b9f07ddadcf10400fb3382dd17e76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1234b2417c566e783de591e2f4c9d9b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_739e4f70e037ad9df13963db0b775c92 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bea07f8f70fcee75e5d55273e30a5f1f http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8019-3380 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6fa007adb183f91f0b4baaa6a349aba5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b03e7f3fc6f06d6e8ea99a1353de3311 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_751dae765c436cd3052cc2a43f2b5c01
date	2022-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36089914 https://doi.org/10.1002/glia.24271
isPartOf	https://portal.issn.org/resource/ISSN/0894-1491 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4226 https://portal.issn.org/resource/ISSN/1098-1136
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation
discusses	http://id.nlm.nih.gov/mesh/M0376295 http://id.nlm.nih.gov/mesh/M0579317 http://id.nlm.nih.gov/mesh/M0046983
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000074586Q000502 http://id.nlm.nih.gov/mesh/D009471Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007074 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000077553Q000378 http://id.nlm.nih.gov/mesh/D009186Q000378 http://id.nlm.nih.gov/mesh/D000076222Q000378 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D009836Q000378 http://id.nlm.nih.gov/mesh/D002454Q000502 http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7405 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82029 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4021 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7001 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8656

Total number of triples: 58.